「for」の検索結果
121件：21～25件目を表示
-
学会发表 | 研究与开发 | 千寿制药株式会社
non-clinical ocular instillation toxicity studies of SJP-0132, a TRPV1 antagonist, a novel eye drop for dry eye disease Hideya Yonekura, Kotaro Yamada, Gen Suzuki, Yu Haranosono, Yoshinori Yamagiwa, I...
http://www.senju.co.jp/chinese/rd/society/ -
临床试验信息 | 研究与开发 | 千寿制药株式会社
Dry Eye Disease 1/2 SJP-0132 United States Completed NCT04139122 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as...
http://www.senju.co.jp/chinese/rd/trial.html -
ealth and prosperity by the realization and synergy of Senju’s mission of the “Pursuit of happiness for all people”, and Rexxam’s` policy the “Take boldly on any challenge, while putting ourselves in ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye...
http://www.senju.co.jp/english/rd/pipeline.html -
产品开发方针 | 研究与开发 | 千寿制药株式会社
heng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16. #1...
http://www.senju.co.jp/chinese/rd/policy/